First patient enrolled in Part B of Phase 2 ASCEND study enabled by availability of drug product from new manufacturing process —— Topline data ...
Indo-MIM's Rs 3,811 crore IPO is in its final bidding day with robust demand. The IPO has been subscribed 3.07 times by the ...
Wearable diagnostics, implantable monitors, and minimally invasive surgical instruments fuel demand for smaller components.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results